Form D · Pharmaceuticals
Enlaza Therapeutics, Inc.
La Jolla, CA · CIK 0001852950
Offering snapshot reported Sep 11, 2025 · SEC filing
- Reported sold
- $15M Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Aug 29, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 11, 2025 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
| Aug 9, 2024 | Initial | $84,000,000 | No comparison | 16 | SEC filing |
| Nov 22, 2022 | Amendment | $35,299,237 | $31,280,607vs Mar 25, 2021 | 10 | SEC filing |
| Oct 13, 2022 | Initial | $0 | No comparison | 1 | SEC filing |
| Oct 13, 2022 | Initial | $0 | No comparison | 1 | SEC filing |
| Aug 13, 2021 | Initial | $0 | No comparison | Not reported | SEC filing |
| Jun 28, 2021 | Initial | $0 | No comparison | 1 | SEC filing |
| Mar 25, 2021 | Initial | $4,018,630 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-557255
Source: Form D, filed Sep 11, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shelley Chu | Director |
| Sergio Duron | Director, Executive |
| Jay Lichter | Director |
| Sanford Madigan | Executive |
| Marcos Milla | Director |
| Tighe Reardon | Executive |
| Stephen Squinto | Director |
| James Topper | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
11099 North Torrey Pines Road, Ste. 280
La Jolla, CA, 92037
Phone: 858-348-2180
La Jolla, CA, 92037
Phone: 858-348-2180